Toda G - Search Results

1

Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia.

Sawada K, Masaki N, Hayashi S, Zeniya M, Ishikawa T, Takahashi H, Ohnishi K, Fukunaga K, Hara N, Yamamoto T, Hada T, Toda G. Sawada K, et al. Among authors: toda g. J Viral Hepat. 2005 May;12(3):274-82. doi: 10.1111/j.1365-2893.2005.00577.x. J Viral Hepat. 2005. PMID: 15850468 Clinical Trial.

2

Role of nitric oxide (NO) in interferon-alpha therapy for hepatitis C.

Hokari A, Zeniya M, Esumi H, Ishikawa T, Kurasima Y, Toda G. Hokari A, et al. Among authors: toda g. J Infect. 2005 Jul;51(1):47-53. doi: 10.1016/j.jinf.2004.08.025. J Infect. 2005. PMID: 15979491

3

Case selection for interferon treatment of hepatitis C.

Zeniya M, Toda G. Zeniya M, et al. Among authors: toda g. J Gastroenterol Hepatol. 2000 May;15 Suppl:E117-22. doi: 10.1046/j.1440-1746.2000.02111.x. J Gastroenterol Hepatol. 2000. PMID: 10921393

4

Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.

Izumi N, Kumada H, Hashimoto N, Harada H, Imawari M, Zeniya M, Toda G. Izumi N, et al. Among authors: toda g. Dig Dis Sci. 2001 Mar;46(3):516-23. doi: 10.1023/a:1005686829416. Dig Dis Sci. 2001. PMID: 11318525 Clinical Trial.

5

Naturally occurring anti-interferon-alpha 2a antibodies in patients with acute viral hepatitis.

Ikeda Y, Toda G, Hashimoto N, Umeda N, Miyake K, Yamanaka M, Kurokowa K. Ikeda Y, et al. Among authors: toda g. Clin Exp Immunol. 1991 Jul;85(1):80-4. doi: 10.1111/j.1365-2249.1991.tb05686.x. Clin Exp Immunol. 1991. PMID: 1906385 Free PMC article.

6

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.

Omata M, Yoshida H, Toyota J, Tomita E, Nishiguchi S, Hayashi N, Iino S, Makino I, Okita K, Toda G, Tanikawa K, Kumada H; Japanese C-Viral Hepatitis Network. Omata M, et al. Among authors: toda g. Gut. 2007 Dec;56(12):1747-53. doi: 10.1136/gut.2007.120956. Epub 2007 Jun 15. Gut. 2007. PMID: 17573387 Free PMC article. Clinical Trial.

7

Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.

Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G. Aizawa Y, et al. Among authors: toda g. Cancer. 2000 Jul 1;89(1):53-9. Cancer. 2000. PMID: 10897000

8

Detection of anti-interferon-alpha 2a antibodies in chronic liver disease.

Ikeda Y, Miyake K, Toda G, Yamada H, Yamanaka M, Oka H. Ikeda Y, et al. Among authors: toda g. J Gastroenterol Hepatol. 1989 Sep-Oct;4(5):411-8. doi: 10.1111/j.1440-1746.1989.tb01738.x. J Gastroenterol Hepatol. 1989. PMID: 2491207

9

[Anti-calmodulin antibody].

Hashimoto N, Ikeda Y, Toda G. Hashimoto N, et al. Among authors: toda g. Nihon Rinsho. 2010 Jun;68 Suppl 6:697-700. Nihon Rinsho. 2010. PMID: 20942167 Japanese. No abstract available.

10

[A case of groove pancreatitis pure type treated with conservative therapy].

Suto S, Okuaki Y, Matsuoka M, Enomoto Y, Tsuruta Y, Miyagawa Y, Saito A, Aizawa Y, Toda G. Suto S, et al. Among authors: toda g. Nihon Shokakibyo Gakkai Zasshi. 2003 Jul;100(7):884-8. Nihon Shokakibyo Gakkai Zasshi. 2003. PMID: 12884767 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results